A year after its nationwide launch, the Pharmacy First scheme is earning high marks from patients, with nearly nine in ten users reporting a positive experience when consulting their pharmacist for common health conditions.

The programme, which allows patients to access treatment for selected minor illnesses without needing to see a GP, has been hailed as a step forward in easing NHS pressures and improving accessibility.

Two customers at a pharmacy counter

However, despite its success, the scheme still faces notable challenges that could limit its long-term impact. According to a new report from Healthwatch England, issues such as medicine shortages, lack of patient awareness, and privacy concerns during consultations are proving persistent.

“Pharmacy First is clearly working, and public confidence in pharmacists as frontline healthcare providers is strong,” the report states. “But for the scheme to achieve its full potential, these barriers must be addressed.”

The findings show overwhelming public support not only for maintaining Pharmacy First but also for expanding its scope to cover more conditions. Yet, the report urges that several actions are needed to strengthen the programme:

  • Improved public communication about which conditions are covered under Pharmacy First.

  • Better stock management and supply chains to avoid medicine shortages.

  • Enhanced consultation spaces to ensure privacy and dignity for patients.

Commenting on the findings, Louise Ansari, Chief Executive of Healthwatch England said:

“Pharmacy First is clearly delivering for patients—people value the speed, convenience, and expertise that community pharmacists offer and support getting help with more conditions. But to unlock its full potential, we must tackle the barriers holding some people back. 

“Most concerning is the rise in problems people face in being able to access medications, a situation which is both frustrating and distressing for many patients. 

“International supply issues will take time to resolve, but the NHS can act now to reduce the impact on patients. Providing clear guidance and giving pharmacists more flexibility to prescribe substitutes safely could make a real difference in people’s lives.

“The NHS must also invest in improving privacy in pharmacies and ensuring everyone knows what support is available. 

“With the right investment, Pharmacy First could play an even more vital role in easing pressure on GPs and improving access to care for millions.”

For more information, and to read the report, please visit Healthwatch England’s website.